{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:46:38Z","timestamp":1787507198228,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Sichuan Provincial Science and Technology Support Project","award":["2025ZNSFSC0698"],"award-info":[{"award-number":["2025ZNSFSC0698"]}]},{"name":"the Sichuan Provincial Science and Technology Support Project","award":["2024YFFK0303"],"award-info":[{"award-number":["2024YFFK0303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04956-w","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:16:11Z","timestamp":1780463771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of treatment response to subthreshold micropulse laser and oral spironolactone therapy for central serous chorioretinopathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"4956_CR1","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.preteyeres.2020.100865","volume":"79","author":"R Kaye","year":"2020","unstructured":"Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res. 2020;79:100865.","journal-title":"Prog Retin Eye Res"},{"key":"4956_CR2","doi-asserted-by":"crossref","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG et al. Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res 2024:101236.","DOI":"10.1016\/j.preteyeres.2024.101236"},{"key":"4956_CR3","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770.","journal-title":"Prog Retin Eye Res"},{"key":"4956_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/bjophthalmol-2020-317422","volume":"106","author":"SR Singh","year":"2022","unstructured":"Singh SR, Iovino C, Zur D, et al. Central serous chorioretinopathy imaging biomarkers. Br J Ophthalmol. 2022;106:553\u20138.","journal-title":"Br J Ophthalmol"},{"key":"4956_CR5","doi-asserted-by":"publisher","first-page":"204062232211467","DOI":"10.1177\/20406223221146721","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zheng W, Sun Z, et al. Optical coherence tomography biomarkers as predictors of transition to chronic central serous chorioretinopathy after retinal laser photocoagulation. Ther Adv Chronic Dis. 2023;14:20406223221146721.","journal-title":"Ther Adv Chronic Dis"},{"key":"4956_CR6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10103-020-03225-6","volume":"36","author":"MG Alt\u0131nel","year":"2021","unstructured":"Alt\u0131nel MG, Acikalin B, Gunes H, et al. Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy. Lasers Med Sci. 2021;36:1505\u201314.","journal-title":"Lasers Med Sci"},{"key":"4956_CR7","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s10103-022-03574-4","volume":"37","author":"P Kiraly","year":"2022","unstructured":"Kiraly P, Smrekar J, Jaki Mekjavi\u0107 P. Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy. Lasers Med Sci. 2022;37:3129\u201336.","journal-title":"Lasers Med Sci"},{"key":"4956_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12886-022-02472-1","volume":"22","author":"F Zheng","year":"2022","unstructured":"Zheng F, He J, Su Z, et al. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy. BMC Ophthalmol. 2022;22:252.","journal-title":"BMC Ophthalmol"},{"key":"4956_CR9","doi-asserted-by":"crossref","unstructured":"Borrelli E, Zuccaro B, Zucchiatti I, et al. Optical coherence tomography parameters as predictors of treatment response to eplerenone in central serous chorioretinopathy. J Clin Med 2019; 8.","DOI":"10.3390\/jcm8091271"},{"key":"4956_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2018.09.034","volume":"198","author":"E Bousquet","year":"2019","unstructured":"Bousquet E, Dhundass M, Lejoyeux R, et al. Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy. Am J Ophthalmol. 2019;198:80\u20137.","journal-title":"Am J Ophthalmol"},{"key":"4956_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/IAE.0000000000001303","volume":"37","author":"R Gergely","year":"2017","unstructured":"Gergely R, Kov\u00e1cs I, Schneider M, et al. Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: a comparative study of exudative and nonexudative fellow eyes. Retina. 2017;37:1084\u201391.","journal-title":"Retina"},{"key":"4956_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/aos.14901","volume":"100","author":"Y Subhi","year":"2022","unstructured":"Subhi Y, Bjerager J, Boon CJF, et al. Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data. Acta Ophthalmol. 2022;100:89\u201395.","journal-title":"Acta Ophthalmol"},{"key":"4956_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-023-02628-3","volume":"146","author":"B Leclercq","year":"2023","unstructured":"Leclercq B, Weiner A, Zola M, et al. The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid. Acta Neuropathol. 2023;146:747\u201366.","journal-title":"Acta Neuropathol"},{"key":"4956_CR14","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.exer.2019.107754","volume":"187","author":"E Bousquet","year":"2019","unstructured":"Bousquet E, Zhao M, Daruich A, et al. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence. Exp Eye Res. 2019;187:107754.","journal-title":"Exp Eye Res"},{"key":"4956_CR15","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/OPTH.S411094","volume":"17","author":"G Boscia","year":"2023","unstructured":"Boscia G, Viggiano P, Marzulli F, et al. Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study. Clin Ophthalmol. 2023;17:2003\u201312.","journal-title":"Clin Ophthalmol"},{"key":"4956_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40123-022-00625-5","volume":"12","author":"M Gaw\u0119cki","year":"2023","unstructured":"Gaw\u0119cki M, Grzybowski A. Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy. Ophthalmol Ther. 2023;12:517\u201333.","journal-title":"Ophthalmol Ther"},{"key":"4956_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/08820538.2020.1809682","volume":"35","author":"TP Vignesh","year":"2020","unstructured":"Vignesh TP, Maitray A, Sen S, et al. Subthreshold Micro-Pulse Yellow Laser and Eplerenone Drug Therapy in Chronic Central Serous Chorio-Retinopathy Patients: A Comparative Study. Semin Ophthalmol. 2020;35:237\u201345.","journal-title":"Semin Ophthalmol"},{"key":"4956_CR18","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","volume":"33","author":"E Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M, et al. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2013;33:2096\u2013102.","journal-title":"Retina"},{"key":"4956_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/IAE.0000000000003845","volume":"43","author":"E Borrelli","year":"2023","unstructured":"Borrelli E, Barresi C, Battista M, et al. Prevalence and morphologic biomarkers of metamorphopsia in eyes with resolved chronic central serous chorioretinopathy. Retina. 2023;43:1563\u201372.","journal-title":"Retina"},{"key":"4956_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3341\/kjo.2012.26.5.347","volume":"26","author":"HC Kim","year":"2012","unstructured":"Kim HC, Cho WB, Chung H. Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography. Korean J Ophthalmol. 2012;26:347\u201354.","journal-title":"Korean J Ophthalmol"},{"key":"4956_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/bjo.2004.049403","volume":"89","author":"JA Montero","year":"2005","unstructured":"Montero JA, Ruiz-Moreno JM. Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy. Br J Ophthalmol. 2005;89:562\u20134.","journal-title":"Br J Ophthalmol"},{"key":"4956_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2147\/OPTH.S48894","volume":"8","author":"AM Plateroti","year":"2014","unstructured":"Plateroti AM, Witmer MT, Kiss S, et al. Characteristics of intraretinal deposits in acute central serous chorioretinopathy. Clin Ophthalmol. 2014;8:673\u20136.","journal-title":"Clin Ophthalmol"},{"key":"4956_CR23","doi-asserted-by":"crossref","unstructured":"Viggiano P, Scotti G, Termite AC, et al. Choroidal remodeling after subthreshold micropulse laser in chronic central serous chorioretinopathy: short-term outcomes. J Clin Med 2025; 14.","DOI":"10.3390\/jcm14020306"},{"key":"4956_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","volume":"111","author":"R Haimovici","year":"2004","unstructured":"Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111:244\u20139.","journal-title":"Ophthalmology"},{"key":"4956_CR25","first-page":"1344","volume":"27","author":"R Li","year":"2018","unstructured":"Li R, Yu K, Li C. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review. Asia Pac J Clin Nutr. 2018;27:1344\u201356.","journal-title":"Asia Pac J Clin Nutr"},{"key":"4956_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10067-012-2108-z","volume":"32","author":"L Liu","year":"2013","unstructured":"Liu L, Lou S, Xu K, et al. Relationship between lifestyle choices and hyperuricemia in Chinese men and women. Clin Rheumatol. 2013;32:233\u20139.","journal-title":"Clin Rheumatol"},{"key":"4956_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1530-0277.1991.tb00543.x","volume":"15","author":"LA Pohorecky","year":"1991","unstructured":"Pohorecky LA. Stress and alcohol interaction: an update of human research. Alcohol Clin Exp Res. 1991;15:438\u201359.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04956-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04956-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04956-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:52:15Z","timestamp":1786060335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04956-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4956"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04956-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was registered on ChiCTR (identifier: ChiCTR2100044356). The study adhered to the principles of the Declaration of Helsinki and was approved by the West China Hospital of Sichuan University Biomedical Research Ethics Committee (identifier: 20201187). All patients signed an informed consent form.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"471"}}